Latest News and Press Releases

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Cardiac Amyloidosis Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been...

PARIS, 18 juin 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies annonce ce jour son admission au programme pilote TAP (Total Product Life Cycle Advisory Program, programme consultatif sur...

PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food...

Dublin, June 11, 2025 (GLOBE NEWSWIRE) -- The "Congestive Heart Failure (CHF) Epidemiology Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.Heart failure is a...

PARIS, 19 mai 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies a annoncé aujourd’hui que son système de dénervation pulmonaire a reçu la désignation de dispositif innovant de la part de la...

PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and...

VITAS is the first national hospice provider to earn the American Heart Association Heart Failure certification across all 15 states in which it operates.

Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Cardiogenic Shock Market: Analysis by Treatment Type, End User, and Region - Growth Trends and Forecast to 2030" report has been added to ...

Inflammasome inhibition in obese animal model with heart failure was cardioprotective & improved metabolic parameters.

Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "Heart Failure: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the 68...